Satellos Bioscience Inc.
MSCLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $19,304 | $38,217 | $32,712 | $57,659 |
| Short-Term Investments | $15,310 | $0 | $8,478 | $12,195 |
| Receivables | $205 | $186 | $338 | $626 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,678 | $2,709 | $2,837 | $2,532 |
| Total Curr. Assets | $37,497 | $41,112 | $44,365 | $73,012 |
| Property Plant & Equip (Net) | $6 | $5 | $3 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $6 | $5 | $3 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $37,503 | $41,117 | $44,368 | $73,017 |
| Liabilities | – | – | – | – |
| Payables | $1,385 | $1,060 | $1,885 | $2,968 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $114 | $95 | $63 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,004 | $1,615 | $751 | $2,187 |
| Total Curr. Liab. | $3,503 | $2,770 | $2,699 | $5,155 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,503 | $2,770 | $2,699 | $5,155 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $85,546 | $82,512 | $78,134 | $105,729 |
| Retained Earnings | -$74,667 | -$68,846 | -$63,238 | -$75,601 |
| AOCI | -$1,675 | -$1,675 | -$1,541 | -$217 |
| Other Equity | $24,796 | $26,356 | $28,314 | $37,951 |
| Total Equity | $34,000 | $38,347 | $41,669 | $67,862 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $37,503 | $41,117 | $44,368 | $73,017 |
| Net Debt | -$19,304 | -$38,217 | -$32,712 | -$57,659 |